Portfolio Updates

• 10/22/2024

  Unraveling the Enigma: Schrödinger, Inc.’s Complex Journey

• 10/19/2024

  Protagonist Therapeutics: Solid Outlook, But Is the Stock Worth It?

• 10/8/2024

  **CureVac’s Setback**

• 9/30/2024

  **Pessimistic About a Soft Landing**

• 9/29/2024

  **Q3 2024 Portfolio Update**